Ayurvedic Treatment for Intra-ocular Hypertension (Glaucoma)
- Conditions
- Other specified disorders of eye and adnexa,
- Registration Number
- CTRI/2020/08/027255
- Lead Sponsor
- Dr Arun Das
- Brief Summary
The study is a randomized controlled clinical study to evaluate the Efficacy of Ayurvedic protocol (Nasya, Pindi Bidalaka and Anjana) in intra ocular hydrops or ocular hypertension and to compare with Standard Anti glaucoma medication (Timolol Melatate 0.5%) for a period of 45 days. Study will be conducted in KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya and Research centre owned KLE Ayurveda Hospital Shahapur BELAGAVI Karnataka India . The expected outcome is to bring down the raised IOP to standard target IOP and prevent the consequences resulting out of intraocular hydrops
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 20
IOP between 22 to 30 mm of Hg(Asymptomatic cases but noticed raised IOP during routine ophthalmic investigations) Age group 30 to 70years Irrespective of sex, occupation Controlled systemic ailments like DM & HTN Known cases of POAG with existing standard anti-glaucoma medication with Timilol Maleate 0.5%.
Acute Angle closure glaucoma IOP ranging above 30mm of Hg Un-controlled systemic disorders like DM, HTN, COPD, Renal pathologies End-stage / advanced glaucomatous optic neuropathywith sever visual morbidity.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The developed Ayurvedic Protocol may be effective in maanaging IOP at its trget 45 days
- Secondary Outcome Measures
Name Time Method The developed protocol may be effective in Preventing complications of ocular hydrops 45 days
Trial Locations
- Locations (1)
OPD No 27
🇮🇳Belgaum, KARNATAKA, India
OPD No 27🇮🇳Belgaum, KARNATAKA, IndiaDr Arun DasPrincipal investigator9164537685drarundasayu@gmail.com